[go: up one dir, main page]
More Web Proxy on the site http://driver.im/ Skip to main content

Advertisement

Springer Nature Link
Log in

The Tumor Suppressor Function of Human Sulfatase 1 (SULF1) in Carcinogenesis

  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

Abstract

Introduction

Human sulfatase 1 (SULF1) was recently identified and shown to desulfate cellular heparan sulfate proteoglycans (HSPGs). Since sulfated HSPGs serve as co-receptors for many growth factors and cytokines, SULF1 was predicted to modulate growth factor and cytokine signaling.

Discussion

The role of SULF1 in growth factor signaling and its effects on human tumorigenesis are under active investigation. Initial results show that SULF1 inhibits the co-receptor function of HSPGs in multiple receptor tyrosine kinase signaling pathways, particularly by the heparin binding growth factors—fibroblast growth factor 2, vascular endothelial growth factor, hepatocyte growth factor, PDGF, and heparin-binding epidermal growth factor (HB-EGF). SULF1 is downregulated in the majority of cancer cell lines examined, and forced expression of SULF1 decreases cell proliferation, migration, and invasion. SULF1 also promotes drug-induced apoptosis of cancer cells in vitro and inhibits tumorigenesis and angiogenesis in vivo.

Conclusion

Strategies targeting SULF1 or the interaction between SULF1 and the related sulfatase 2 will potentially be important in developing novel cancer therapies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
£29.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price includes VAT (United Kingdom)

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Diez-Roux G, Ballabio A. Sulfatases and human disease. Annu Rev Genomics Hum Genet. 2005;6:355–79. doi:10.1146/annurev.genom.6.080604.162334.

    Article  PubMed  CAS  Google Scholar 

  2. Shridhar V, Sen A, Chien J, Staub J, Avula R, Kovats S, et al. Identification of underexpressed genes in early- and late-stage primary ovarian tumors by suppression subtraction hybridization. Cancer Res. 2002;62 1:262–70.

    PubMed  CAS  Google Scholar 

  3. Ai X, Do AT, Kusche-Gullberg M, Lindahl U, Lu K, Emerson CP Jr. Substrate specificity and domain functions of extracellular heparan sulfate 6-O-endosulfatases, QSulf1 and QSulf2. J Biol Chem. 2006;281 8:4969–76. doi:10.1074/jbc.M511902200.

    Article  PubMed  CAS  Google Scholar 

  4. Dhoot GK, Gustafsson MK, Ai X, Sun W, Standiford DM, Emerson CP Jr. Regulation of Wnt signaling and embryo patterning by an extracellular sulfatase. Science. 2001;293 5535:1663–6. doi:10.1126/science.293.5535.1663.

    Article  PubMed  CAS  Google Scholar 

  5. Lai J, Chien J, Staub J, Avula R, Greene EL, Matthews TA, et al. Loss of HSulf-1 up-regulates heparin-binding growth factor signaling in cancer. J Biol Chem. 2003;278 25:23107–17. doi:10.1074/jbc.M302203200.

    Article  PubMed  CAS  Google Scholar 

  6. Lai JP, Chien JR, Moser DR, Staub JK, Aderca I, Montoya DP, et al. hSulf1 sulfatase promotes apoptosis of hepatocellular cancer cells by decreasing heparin-binding growth factor signaling. Gastroenterology. 2004;126 1:231–48. doi:10.1053/j.gastro.2003.09.043.

    Article  PubMed  CAS  Google Scholar 

  7. Forsten-Williams K, Chu CL, Fannon M, Buczek-Thomas JA, Nugent MA. Control of growth factor networks by heparan sulfate proteoglycans. Ann Biomed Eng. 2008;36 12:2134–48. doi:10.1007/s10439-008-9575-z.

    Article  PubMed  Google Scholar 

  8. Kikuno R, Nagase T, Ishikawa K, Hirosawa M, Miyajima N, Tanaka A, et al. Prediction of the coding sequences of unidentified human genes. XIV. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro. DNA Res. 1999;6 3:197–205. doi:10.1093/dnares/6.3.197.

    Article  PubMed  CAS  Google Scholar 

  9. Morimoto-Tomita M, Uchimura K, Werb Z, Hemmerich S, Rosen SD. Cloning and characterization of two extracellular heparin-degrading endosulfatases in mice and humans. J Biol Chem. 2002;277 51:49175–85. doi:10.1074/jbc.M205131200.

    Article  PubMed  CAS  Google Scholar 

  10. Ohto T, Uchida H, Yamazaki H, Keino-Masu K, Matsui A, Masu M. Identification of a novel nonlysosomal sulphatase expressed in the floor plate, choroid plexus and cartilage. Genes Cells. 2002;7 2:173–85. doi:10.1046/j.1356-9597.2001.00502.x.

    Article  PubMed  CAS  Google Scholar 

  11. Staub J, Chien J, Pan Y, Qian X, Narita K, Aletti G, et al. Epigenetic silencing of HSulf-1 in ovarian cancer: implications in chemoresistance. Oncogene. 2007;26 34:4969–78. doi:10.1038/sj.onc.1210300.

    Article  PubMed  CAS  Google Scholar 

  12. Lai JP, Chien J, Strome SE, Staub J, Montoya DP, Greene EL, et al. HSulf-1 modulates HGF-mediated tumor cell invasion and signaling in head and neck squamous carcinoma. Oncogene. 2004;23 7:1439–47. doi:10.1038/sj.onc.1207258.

    Article  PubMed  CAS  Google Scholar 

  13. Narita K, Chien J, Mullany SA, Staub J, Qian X, Lingle WL, et al. Loss of HSulf-1 expression enhances autocrine signaling mediated by amphiregulin in breast cancer. J Biol Chem. 2007;282 19:14413–20. doi:10.1074/jbc.M611395200.

    Article  PubMed  CAS  Google Scholar 

  14. Li J, Kleeff J, Abiatari I, Kayed H, Giese NA, Felix K, et al. Enhanced levels of Hsulf-1 interfere with heparin-binding growth factor signaling in pancreatic cancer. Mol Cancer. 2005;4 1:14. doi:10.1186/1476-4598-4-14.

    Article  PubMed  Google Scholar 

  15. Nawroth R, van Zante A, Cervantes S, McManus M, Hebrok M, Rosen SD. Extracellular sulfatases, elements of the Wnt signaling pathway, positively regulate growth and tumorigenicity of human pancreatic cancer cells. PLoS ONE. 2007;2 4:e392. doi:10.1371/journal.pone.0000392.

    Article  PubMed  Google Scholar 

  16. Soule HD, Maloney TM, Wolman SR, Peterson WD Jr, Brenz R, McGrath CM, et al. Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10. Cancer Res. 1990;50 18:6075–86.

    PubMed  CAS  Google Scholar 

  17. Cross SH, Charlton JA, Nan X, Bird AP. Purification of CpG islands using a methylated DNA binding column. Nat Genet. 1994;6 3:236–44. doi:10.1038/ng0394-236.

    Article  PubMed  CAS  Google Scholar 

  18. Chen Z, Fan JQ, Li J, Li QS, Yan Z, Jia XK, et al. Promoter hypermethylation correlates with the Hsulf-1 silencing in human breast and gastric cancer. Int J Cancer. 2009;124 3:739–44. doi:10.1002/ijc.23960.

    Article  PubMed  CAS  Google Scholar 

  19. Ai X, Do AT, Lozynska O, Kusche-Gullberg M, Lindahl U, Emerson CP Jr. QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling. J Cell Biol. 2003;162 2:341–51. doi:10.1083/jcb.200212083.

    Article  PubMed  CAS  Google Scholar 

  20. Lundin L, Larsson H, Kreuger J, Kanda S, Lindahl U, Salmivirta M, et al. Selectively desulfated heparin inhibits fibroblast growth factor-induced mitogenicity and angiogenesis. J Biol Chem. 2000;275 32:24653–60. doi:10.1074/jbc.M908930199.

    Article  PubMed  CAS  Google Scholar 

  21. Delehedde M, Lyon M, Gallagher JT, Rudland PS, Fernig DG. Fibroblast growth factor-2 binds to small heparin-derived oligosaccharides and stimulates a sustained phosphorylation of p42/44 mitogen-activated protein kinase and proliferation of rat mammary fibroblasts. Biochem J. 2002;366 Pt 1:235–44.

    PubMed  CAS  Google Scholar 

  22. Wang S, Ai X, Freeman SD, Pownall ME, Lu Q, Kessler DS, et al. QSulf1, a heparan sulfate 6-O-endosulfatase, inhibits fibroblast growth factor signaling in mesoderm induction and angiogenesis. Proc Natl Acad Sci USA. 2004;101 14:4833–8. doi:10.1073/pnas.0401028101.

    Article  PubMed  CAS  Google Scholar 

  23. Dong G, Chen Z, Li ZY, Yeh NT, Bancroft CC, Van Waes C. Hepatocyte growth factor/scatter factor-induced activation of MEK and PI3K signal pathways contributes to expression of proangiogenic cytokines interleukin-8 and vascular endothelial growth factor in head and neck squamous cell carcinoma. Cancer Res. 2001;61 15:5911–8.

    PubMed  CAS  Google Scholar 

  24. Dong G, Lee TL, Yeh NT, Geoghegan J, Van Waes C, Chen Z. Metastatic squamous cell carcinoma cells that overexpress c-Met exhibit enhanced angiogenesis factor expression, scattering and metastasis in response to hepatocyte growth factor. Oncogene. 2004;23 37:6199–208. doi:10.1038/sj.onc.1207851.

    Article  PubMed  CAS  Google Scholar 

  25. Matsumoto K, Matsumoto K, Nakamura T, Kramer RH. Hepatocyte growth factor/scatter factor induces tyrosine phosphorylation of focal adhesion kinase (p125FAK) and promotes migration and invasion by oral squamous cell carcinoma cells. J Biol Chem. 1994;269 50:31807–13.

    PubMed  CAS  Google Scholar 

  26. Galeazzi E, Olivero M, Gervasio FC, De Stefani A, Valente G, Comoglio PM, et al. Detection of MET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas. Eur Arch Otorhinolaryngol. 1997;254 Suppl 1:S138–43. doi:10.1007/BF02439745.

    Article  PubMed  Google Scholar 

  27. Narita K, Staub J, Chien J, Meyer K, Bauer M, Friedl A, et al. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo. Cancer Res. 2006;66 12:6025–32. doi:10.1158/0008-5472.CAN-05-3582.

    Article  PubMed  CAS  Google Scholar 

  28. Lai JP, Yu C, Moser CD, Aderca I, Han T, Garvey TD, et al. SULF1 inhibits tumor growth and potentiates the effects of histone deacetylase inhibitors in hepatocellular carcinoma. Gastroenterology. 2006;130 7:2130–44. doi:10.1053/j.gastro.2006.02.056.

    Article  PubMed  CAS  Google Scholar 

  29. Lai J-P, Sandhu D, Moser C, Cazanave S, Oseini A, Shire A, Shridhar V, Sanderson S, Roberts L. Additive effect of apicidin and doxorubicin in sulfatase 1 (SULF1)-expressing hepatocellular carcinoma in vitro and in vivo. J Hepatol. 2009; in press.

  30. Abiatari I, Kleeff J, Li J, Felix K, Buchler MW, Friess H. Hsulf-1 regulates growth and invasion of pancreatic cancer cells. J Clin Pathol. 2006;59 10:1052–8. doi:10.1136/jcp.2005.031716.

    Article  PubMed  CAS  Google Scholar 

  31. Dai Q, Qian SB, Li HH, McDonough H, Borchers C, Huang D, et al. Regulation of the cytoplasmic quality control protein degradation pathway by BAG2. J Biol Chem. 2005;280 46:38673–81. doi:10.1074/jbc.M507986200.

    Article  PubMed  CAS  Google Scholar 

  32. Butler KV, Kozikowski AP. Chemical origins of isoform selectivity in histone deacetylase inhibitors. Curr Pharm Des. 2008;14 6:505–28. doi:10.2174/138161208783885353.

    Article  PubMed  CAS  Google Scholar 

  33. Lamanna WC, Baldwin RJ, Padva M, Kalus I, Ten Dam G, van Kuppevelt TH, et al. Heparan sulfate 6-O-endosulfatases: discrete in vivo activities and functional co-operativity. Biochem J. 2006;400 1:63–73. doi:10.1042/BJ20060848.

    Article  PubMed  CAS  Google Scholar 

  34. Lamanna WC, Frese MA, Balleininger M, Dierks T. Sulf loss influences N-, 2-O-, and 6-O-sulfation of multiple heparan sulfate proteoglycans and modulates fibroblast growth factor signaling. J Biol Chem. 2008;283 41:27724–35. doi:10.1074/jbc.M802130200.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

This study was supported by the Mayo Clinic and Mayo Clinic Cancer Center, NIH Grants CA82862 and CA100882, an Industry Research Scholar Award from the Foundation for Digestive Health and Nutrition, a Harold Amos Medical Faculty Development Award from The Robert Wood Johnson Foundation, a generous gift from The Richard M. Schulze Family Foundation, and the Miles and Shirley Fiterman Center for Digestive Diseases at the Mayo Clinic, Rochester, MN, USA. Dr. Roberts and Mayo Clinic have a potential financial interest associated with technology used in research referenced in this review. The authors thank Vicki Campion for secretarial assistance.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, College of Medicine, Mayo Clinic, Rochester, MN, USA

    Jin-Ping Lai, Dalbir S. Sandhu, Abdirashid M. Shire & Lewis R. Roberts

  2. Miles and Shirley Fiterman Center for Digestive Diseases, College of Medicine, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA

    Lewis R. Roberts

Authors
  1. Jin-Ping Lai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dalbir S. Sandhu
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Abdirashid M. Shire
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Lewis R. Roberts
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Lewis R. Roberts.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lai, JP., Sandhu, D.S., Shire, A.M. et al. The Tumor Suppressor Function of Human Sulfatase 1 (SULF1) in Carcinogenesis. J Gastrointest Canc 39, 149–158 (2008). https://doi.org/10.1007/s12029-009-9058-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-009-9058-y

Keywords

Search

Navigation